Quality of life assessment in Inflammatory Bowel Disease (IBD): German version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; disease-specific instrument for quality of life assessment) - First application and comparison with international investigations;Lebensqualität bei chronisch entzündlichen darmerkrankungen (CED): Die Deutsche version des Inflammatory Bowel Disease Questionnaire (IBDQ-D) zur krankheitsspezifischen lebensqualitätsmessung - Erste anwendung und vergleich mit anderen internationalen fassungen

Gesundheitswesen

Volumn 67, Issue 8-9, 2005, Pages 656-664

  Janke, K H ^a   Steder Neukamm, U ^b   Bauer, M ^a   Raible, A ^a   Meisner, C ^a   Hoffmann, J C ^c   Gregor, M ^a   Klump, B ^a   Hauser W ^d  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Deutsche Morbus Crohn Colitis Ulcerosa Vereinigung eV ^*  (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d KLINIKUM SAARBRÜCKEN   (Germany)

Author keywords

Crohn's disease; Health related quality of life; IBDQ D; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; FEMALE; GERMANY; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL RESEARCH; OUTPATIENT; PSYCHOMETRY; QUALITY CONTROL; QUALITY OF LIFE; QUESTIONNAIRE; ULCERATIVE COLITIS;

ADULT; DATA COLLECTION; FEMALE; GERMANY; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; PILOT PROJECTS; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 26944498641     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858579     Document Type: Article

References (47)

1. Häuser W, Grandi D. Lebensqualitätsmessung in der Gastroenterologie - Konzepte, Instrumente und Probleme. Z Gastroenterol 2001; 39: 475-481
2. Lopez-Vivancos J, Casellas F, Badia X et al. Validation of the Spanish Version of the Inflammatory Bowel Disease Questionnaire on Ulcerative Colitis and Crohn's Disease. Digestion 1999; 60: 274-280
3. Guyatt G, Mitchell A, Irvine EJ et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96 (3): 804-810
4. Irvine EJ. Quality of Life - Rationale and Methods for Developing a Disease-specific Instrument for Inflammatory Bowel Disease. Scand J Gastroenterol 1993; 28 Suppl 199: 22-27
5. Love JR, Irvine EJ, Fedorak N. Quality of Life in Inflammatory Bowel Disease. J Clin Gastroenterol 1992; 14(1): 15-19
6. nd Edition. Philadelphia: Lippincott-Raven, 1996: 925-935
7. Drossmann DA, Patrick DL, Mitchel CM et al. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989; 34: 1379-1386
8. Testa MA, Simson DC. Assessment of Quality of life outcomes. New England Journal of Medicine 1996; 334(13): 835-840
9. www.who.int/about/definition/en
10. Ellert U, Knopf H. Satisfaction with living conditions and health. Gesundheitswesen 1999; 61: 145-150
11. Priebe S, Kaiser W, Huxley P. Quality of life as a planning and evaluation criterion in psychiatric management. Gesundheitswesen 1996; 58 (Suppl 1): 86-90
12. Ravens-Sieberer U, Holling H, Bettge S et al. Assessment of psychological health and quality of life with The Child and Adolescent Health Survey. Gesundheitswesen 2002; 64 (Suppl 1): 30-35
13. Mitchell A, Guyatt G, Singer J et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988; 10: 306-310
14. Pukrop R. Möller HJ, Saß H et al. Quality of Life. A contribution to construct validation and the development of a modular system. Nervenarzt 1999; 70: 41-53
15. Han SW, McColl E, Steen N et al. The Inflammatory Bowel Disease Questionnaire: A Valid and Reliable Measure in Ulcerative Colitis Patients in the North East of England. Scand J Gastroenterol 1998; 33: 961-966
16. de Boer AGEM et al. Inflammatory Bowel Disease Questionnaire: cross-cultural adaption and further validation. European Journal of Gastroenterology & Hepatology 1995; 7: 1043-1050
17. Russel MGVM et al. Validation of the Dutch Translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): A Health-Related Quality of Life Questionnaire in Inflammatory Bowel Disease. Digestion 1997; 58 (3): 282-288
18. Kim WH et al. Quality of life in Koreans patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behcet's disease. Int J Colorect Dis 1999; 14: 52-57
19. Pallis AG, Vlachonikolis IG, Mouzas IG. Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnaire. Digestion 2001; 63: 240-246
20. Bernklev T, Mourn B, Mourn T(IBSEN). Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the norwegian version of IBDQ. Scand J Gastroenterol 2002; 37: 1164-1174
21. Hjortswang H et al. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis. Scand J Gastroenterol 2001; 36: 77-85
22. Leong RWL et al. Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the inflammatory bowel disease questionnaire. Aliment Pharmacol Ther 2003; 17: 711-718
23. Cheung WY et al. The UK IBDQ - a British version of the inflammatory bowel disease questionnaire: development and validation. J Clin Epidemiol 2000;53:297-306
24. Irvine EJ, Feagan BG, Wong CJ. Does self-administration of a quality of life index for inflammatory bowel disease change the results? J Clin Epidemiol 1996; 49: 1177-1185
25. Irvine EJ, Feagan B, Rochon J et al. (CCRPT). Quality of Life: A Valid and Reliable Measure of Therapeutic Efficacy in the Treatment of Inflammatory Bowel Disease. Gastroenterology 1994; 106: 287-296
26. Sutherland MF, Beck IT, Anderson AH et al. Oral 5ASA versus prednisone in short term treatment of Crohn's disease: a multicentre controlled trial. Can J Gastroenterol 1990; 4: 452-457
27. www.kompetenznetz-ced.de/www.kompetenznetze-medizin.de
28. M = Instrument zur LQ-Erfassung) in inflammatory bowel disease. Int J Colorectal Dis 2004; 19 (4): 343-353
29. Snaith P, Zigmont AS. Hospital anxiety and depression scale: HADS-D. In: Herrmann C, Buss U. (Hrsg). Deutsche Version; ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin; Testdokumentation und Handanweisung. Bern: Huber, 1995
30. Deutsche Arbeitsgemeinschaft Epidemiologie (DAE), Arbeitsgruppe Epidemiologische Methoden. Messung und Quantifizierung soziographischer Merkmale in epidemiologischen Studien. In: Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS), Deutsche Gesellschaft für Sozialmedizin und Prävention (DGSMP), Deutsche Region der Internationalen Biometrischen Gesellschaft (DR-IBS) 1999; DAE-Website: http://medweb.uni. muenster.de/ institute/epi/dae/vorstand.htm#gep
31. Hoffmann W, Latza U, Terschuren C. Guidelines and recommendations for ensuring Good Epidemiological Practice (GEP) - revised version after evaluation. Gesundheitswesen 2005; 67 (3): 217-225
32. Kohlmann T, Bullinger M, Kirchberger-Blumstein I. Die deutsche Version des Nottingham Health Profile (NHP): Übersetzungsmethodik und psychometrische Validierung. Sozial- und Präventivmedizin 1997; 42(3): 175-185
33. Mathias SD, Fifer SK, Patrick DL. Rapid translation of quality of life measures for international clinical trials: avoiding errors in the minimalist approach. Quality of Life Research 1994; 3: 403-412
34. Best WR, Becktel JM, Singelton JW et al. Development of a Crohn's disease activity index. National Cooperative Crohn's disease study. Gastroenterology 1976; 70: 439-444
35. Kjeldsen J, Schafalitzky de Muckadell OB. Review - Assessment of Disease Severity and Activity in inflammatory Bowel Disease. Scand J Gastroenterol 1993; 28: 1-9
36. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1: 514
37. Myren J, Bouchier IAD, Watkinson G et al. The O.M.G.E. multinational inflammatory bowel disease survey 1976-1982. A further report on 2,657 cases. Scand J Gastroenterol 1984; 19 (Suppl. 95): 1-27
38. WHO Technical Report Series No. 854. Geneva: WHO, 1995. http:// chd-taskforce.de/guidelines/kap22.htm and http://www.who.int/dsa/ cat98/nut8.htm#Obesity (and Poverty)
39. Rachmilewitz D. Coated mesalazine (5-amino-salicylic acid) versus sulpasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 1989; 198: 82-86
40. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-1432
41. Pallis AG, Vlachonikolis IG, Mouzas IG. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. BMC Gastroenterology 2002; 2: 1; http://www.biomedcentral.com/1471-230X/2/1
42. Nordin K, Pahllman L, Larsson K et al. Health related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 450-457
43. Latza U, Stang A, Bergmann M et al. The problem of response in epidemiological studies in Germany (part 1). Gesundheitswesen 2004; 66 (5): 326-336
44. Hoffmann W, Terschuren C, Holle R et al. The problem of response in epidemiological studies in Germany (part 2). Gesundheitswesen 2004; 66 (8-9): 482-491
45. Irvine EJ. Quality of Life in Inflammatory Bowel Disease: Biases and Other Factors Affecting Scores. Scand J Gastroenterol 1995; 208: 136-140
46. Cellier C, Sahmoud T, Froguel E et al. and the Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Correlation between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicenter study of 121 cases. Gut 1994; 35: 231-235
47. Sandborn WJ, Feagan BG, Hanauer SB et al. A Review of Activity Indices and Efficacy Endpoints for Clinical Trials of Medical Therapy in Adults With Crohn's Disease. Gastroenterology 2002; 122: 512-530